Phillip Pang - 02 Jan 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP & Chief Medical Officer
Signature
/s/ Sung Lee, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
03 Jan 2024, 14:47:59 UTC
Previous filing
08 Jun 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $16,102 +18,833 +10% $0.8550 206,833 02 Jan 2024 Direct
transaction VIR Common Stock Options Exercise $21,382 +13,576 +6.6% $1.58 220,409 02 Jan 2024 Direct
transaction VIR Common Stock Options Exercise $72,814 +47,591 +22% $1.53 268,000 02 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Options Exercise $16,102 -18,833 -100% $0.8550 0 02 Jan 2024 Common Stock 18,833 $0.8550 Direct F1
transaction VIR Stock Option (Right to Buy) Options Exercise $21,382 -13,576 -100% $1.58 0 02 Jan 2024 Common Stock 13,576 $1.58 Direct F2
transaction VIR Stock Option (Right to Buy) Options Exercise $72,814 -47,591 -100% $1.53 0 02 Jan 2024 Common Stock 47,591 $1.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.
F2 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vested in 36 equal monthly installments thereafter.
F3 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vested in 36 equal monthly installments thereafter.